Baxter International Inc. 

(Public, NYSE:BAX)   Watch this stock   
Find more results for BAX
Nov 11, 2009
Credit Suisse Healthcare Conference
Oct 15, 2009
Q3 2009 Earnings Release
Sep 16, 2009
2009 Investor Conference - Webcast
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 16.92% 16.31%
Operating margin 23.28% 20.64%
EBITD margin - 25.55%
Return on average assets 13.05% 13.12%
Return on average equity 31.18% 30.64%
Employees 48,500 -

Address

One Baxter Parkway
Deerfield, IL 60015
United States - Map
+1-847-9482000 (Phone)
+1-847-9483642 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com
About Company - Wikipedia

Baxter International Inc. discussions

  View all discussions »

Description

Baxter International Inc. (Baxter) develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a diversified healthcare company, Baxter applies a combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, clinical and medical research laboratories, and by patients at home under physician supervision. The Company operates in three segments: The BioScience, Medication Delivery and Renal. The Company’s product portfolio includes anesthesia, biopharmaceuticals, blood collection and transfusion, medication management, oncology, renal and material safety data sheets.

Officers and directors

Robert L. Parkinson Jr.
Chairman of the Board, Chief Executive Officer
Age: 58
Bio & Compensation - Reuters
Robert M. Davis
Chief Financial Officer, Corporate Vice President
Age: 42
Bio & Compensation - Reuters
Karenann K. Terrell
Corporate Vice President, Chief Information Officer
Age: 47
Bio & Compensation - Reuters
Norbert G. Riedel Ph.D.
Corporate Vice President, Chief Scientific Officer
Age: 52
Bio & Compensation - Reuters
Susan R. Lichtenstein
Corporate Vice President, General Counsel
Age: 52
Bio & Compensation - Reuters
Michael J. Baughman
Corporate Vice President, Controller
Age: 44
Bio & Compensation - Reuters
Jeanne K. Mason
Corporate Vice President - Human Resources
Age: 53
Bio & Compensation - Reuters
Peter J. Arduini
Corporate Vice President, President - Medication Delivery
Age: 44
Bio & Compensation - Reuters
Joy A. Amundson
Corporate Vice President, President - BioScience
Age: 54
Bio & Compensation - Reuters
James Michael Gatling
Corporate Vice President - Manufacturing
Age: 59
Bio & Compensation - Reuters